Faithful Mouse Modeling of Human Lung Cancer
Faithful Mouse Modeling of Human Lung Cancer
批准号:
10538424
负责人:
GUTIAN XIAO
金额:
$38.83万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-04-01 至 2025-03-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Abstract
Lung cancer is the leading cause of cancer-related deaths in both men and women with a 5-year survival rate
of only 19%. Although PD-1 immune checkpoint blockade therapy may improve these outcomes, the majority
of lung cancer patients still fail this innovative immunotherapy. One major obstacle in the lung cancer field is
the lack of faithful models that are suitable to identify mechanisms underlying the initiation and progression and
metastasis of human lung cancer and to test new therapeutic strategies against this number 1 cancer killer.
Xenograft, syngeneic or humanized mouse models using established cancer cell lines cannot recapitulate the
natural coevolution of cancer and stromal cells as well as their intricate interplay in the complex micro-
environment. Furthermore, using immunocompromised mice for xenograft transplants precludes the critical
interaction between cancer cells and the immune system. To meet this important challenge, we have recently
generated a novel mouse model of lung cancer, with the full process from tumor initiation to regional and
distant metastasis at a penetrance of 100%. Notably, the metastasis pattern in this endogenous lung cancer
model closely resembles that of its human counterpart in patients. In this application we will systematically
characterize this model, and importantly, examine if it replicates human lung cancer molecularly, genetically
and immuno-phenotypically. We will also establish several complementary models and incorporate them with
the imaging markers luciferase and enhanced green fluorescent protein (EGFP) allowing monitoring and
tracking tumor development and metastasis non-invasively in vivo. These studies will establish faithful models
and provide fundamental knowledge on human lung cancer. They are also highly significant to the cancer field
at large, given the currently limited knowledge on cancer, and in particular, the full process from tumor initiation
to regional and distant metastasis in general.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Faithful mouse modeling of human lung cancer
-
批准号:10198461
-
项目类别:
-
资助金额:$1.68万
-
财政年份:2021
-
负责人:GUTIAN XIAO
-
依托单位:
Modeling ETP-ALL in mouse
-
批准号:8487491
-
项目类别:
-
资助金额:$16.58万
-
财政年份:2013
-
负责人:GUTIAN XIAO
-
依托单位:
PDLIM2 as a cancer and chemosensitizing target
-
批准号:8685914
-
项目类别:
-
资助金额:$30.95万
-
财政年份:2013
-
负责人:GUTIAN XIAO
-
依托单位:
Modeling ETP-ALL in mouse
-
批准号:8642160
-
项目类别:
-
资助金额:$19.46万
-
财政年份:2013
-
负责人:GUTIAN XIAO
-
依托单位:
PDLIM2 as a cancer and chemosensitizing target
-
批准号:9265025
-
项目类别:
-
资助金额:$31.96万
-
财政年份:2013
-
负责人:GUTIAN XIAO
-
依托单位:
PDLIM2 as a cancer and chemosensitizing target
-
批准号:8575709
-
项目类别:
-
资助金额:$31.64万
-
财政年份:2013
-
负责人:GUTIAN XIAO
-
依托单位:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
-
批准号:7494730
-
项目类别:
-
资助金额:$5.37万
-
财政年份:2006
-
负责人:GUTIAN XIAO
-
依托单位:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
-
批准号:7102359
-
项目类别:
-
资助金额:$20.98万
-
财政年份:2006
-
负责人:GUTIAN XIAO
-
依托单位:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
-
批准号:7822944
-
项目类别:
-
资助金额:$22.75万
-
财政年份:2006
-
负责人:GUTIAN XIAO
-
依托单位:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
-
批准号:7406605
-
项目类别:
-
资助金额:$20.85万
-
财政年份:2006
-
负责人:GUTIAN XIAO
-
依托单位:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
-
批准号:7637337
-
项目类别:
-
资助金额:$20.89万
-
财政年份:2006
-
负责人:GUTIAN XIAO
-
依托单位:
HTLV deregulation of NF-kappaB2 p100 processing in tumor
-
批准号:7224210
-
项目类别:
-
资助金额:$15.32万
-
财政年份:2006
-
负责人:GUTIAN XIAO
-
依托单位:
海外基金